Stevanato Group (NYSE:STVN) Trading Down 3.6% - What's Next?

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) shares fell 3.6% on Tuesday . The company traded as low as €21.28 ($23.13) and last traded at €21.54 ($23.41). 11,071 shares traded hands during trading, a decline of 97% from the average session volume of 341,550 shares. The stock had previously closed at €22.35 ($24.29).

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Wolfe Research began coverage on Stevanato Group in a research note on Friday, December 13th. They issued an "outperform" rating and a $28.00 target price for the company. Morgan Stanley reiterated an "equal weight" rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America raised their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a "buy" rating in a research report on Friday, December 13th. UBS Group cut their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Finally, William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of €25.70 ($27.93).

Remove Ads

Stevanato Group Price Performance

The stock has a market capitalization of $6.13 billion, a PE ratio of 43.09, a P/E/G ratio of 7.18 and a beta of 0.60. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The stock's fifty day moving average is €20.90 and its 200-day moving average is €20.59.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting the consensus estimate of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. As a group, equities analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Institutional Trading of Stevanato Group

A number of institutional investors and hedge funds have recently made changes to their positions in STVN. Van Berkom & Associates Inc. purchased a new stake in Stevanato Group in the 4th quarter worth $39,000. Johnson Financial Group Inc. acquired a new stake in Stevanato Group in the 4th quarter worth about $41,000. Wells Fargo & Company MN increased its stake in Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after buying an additional 2,830 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock worth $123,000 after buying an additional 5,291 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock valued at $162,000 after acquiring an additional 4,965 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.